Novo Nordisk enters into collaboration with Danish crispr firm Snipr
The small Danish biotech company Snipr Biome, which uses crispr technology, has landed its first partnership.
BY ELIZABETH MØNSTED JOHANSEN, TRANSLATED BY NIELSINE NIELSEN
Shortly after Snipr Biome managed to bring in new money through its first non-commercial partnership with antimicrobial alliance Carb-X, the Danish company has now managed to find its first commercial partner.
In Jyske Bank’s eyes, Genmab’s newest cancer candidate is almost certain to be approved, though the bank says stock increases in the past year have reduced the upside potential for the Danish biotech firm.
The US retail chain has stopped selling its own private label hearing aids – and until the next generation comes along, other hearing companies selling products via Costco are enjoying the empty shelf space.